Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ludwig scientists working in Sarah De Val's group have discovered that MEF2 transcription factors are crucial regulators of sprouting angiogenesis - the process by which new blood vessels form from existing ones. Their Genes and Development paper shows that MEF2 factors control transcription downstream of vascular endothelial growth factor (VEGF) signalling. VEGF signalling is often targeted in anti-angiogenic cancer therapy.